Forward Pharma A/S (Forward Pharma A/S) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 04, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Forward Pharma A/S's float shares is 0.00 Mil. Forward Pharma A/S's total shares outstanding is 0.02 Mil. Forward Pharma A/S's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Forward Pharma A/S's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Forward Pharma A/S's Institutional Ownership is 0.07%.

Forward Pharma A/S Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Forward Pharma A/S's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	0.00	/	0.02
	=	0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forward Pharma A/S (Forward Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100

Website

https://www.forward-pharma.com

Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.